205 related articles for article (PubMed ID: 28472763)
1. LncRNA OIP5-AS1/cyrano suppresses GAK expression to control mitosis.
Kim J; Noh JH; Lee SK; Munk R; Sharov A; Lehrmann E; Zhang Y; Wang W; Abdelmohsen K; Gorospe M
Oncotarget; 2017 Jul; 8(30):49409-49420. PubMed ID: 28472763
[TBL] [Abstract][Full Text] [Related]
2. LncRNA OIP5-AS1/cyrano sponges RNA-binding protein HuR.
Kim J; Abdelmohsen K; Yang X; De S; Grammatikakis I; Noh JH; Gorospe M
Nucleic Acids Res; 2016 Mar; 44(5):2378-92. PubMed ID: 26819413
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA complementarity and target transcripts abundance.
Zealy RW; Fomin M; Davila S; Makowsky D; Thigpen H; McDowell CH; Cummings JC; Lee ES; Kwon SH; Min KW; Yoon JH
Biochim Biophys Acta Gene Regul Mech; 2018 Mar; 1861(3):224-234. PubMed ID: 29421307
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA OIP5-AS1 in cancer.
Li Y; Han X; Feng H; Han J
Clin Chim Acta; 2019 Dec; 499():75-80. PubMed ID: 31476304
[TBL] [Abstract][Full Text] [Related]
5. The Long Noncoding RNA
Naemura M; Kuroki M; Tsunoda T; Arikawa N; Sawata Y; Shirasawa S; Kotake Y
Anticancer Res; 2018 Jan; 38(1):77-81. PubMed ID: 29277759
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA OIP5-AS1 accelerates CDK14 expression to promote osteosarcoma tumorigenesis via targeting miR-223.
Dai J; Xu L; Hu X; Han G; Jiang H; Sun H; Zhu G; Tang X
Biomed Pharmacother; 2018 Oct; 106():1441-1447. PubMed ID: 30119217
[TBL] [Abstract][Full Text] [Related]
7. LncRNA OIP5-AS1 regulates radioresistance by targeting DYRK1A through miR-369-3p in colorectal cancer cells.
Zou Y; Yao S; Chen X; Liu D; Wang J; Yuan X; Rao J; Xiong H; Yu S; Yuan X; Zhu F; Hu G; Wang Y; Xiong H
Eur J Cell Biol; 2018 Jun; 97(5):369-378. PubMed ID: 29773344
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA OIP5-AS1 aggravates cell proliferation, migration in gastric cancer by epigenetically silencing NLRP6 expression via binding EZH2.
Bai Y; Li S
J Cell Biochem; 2020 Jan; 121(1):353-362. PubMed ID: 31219209
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA OIP5-AS1 functions as an oncogene in lung adenocarcinoma through targeting miR-448/Bcl-2.
Deng J; Deng H; Liu C; Liang Y; Wang S
Biomed Pharmacother; 2018 Feb; 98():102-110. PubMed ID: 29247949
[TBL] [Abstract][Full Text] [Related]
10.
Kotake Y; Matsunaga N; Wakasaki T; Okada R
Cancer Genomics Proteomics; 2021; 18(4):543-548. PubMed ID: 34183387
[TBL] [Abstract][Full Text] [Related]
11. lncRNA OIP5-AS1 targets ROCK1 to promote cell proliferation and inhibit cell apoptosis through a mechanism involving miR-143-3p in cervical cancer.
Song L; Wang L; Pan X; Yang C
Braz J Med Biol Res; 2020; 53(1):e8883. PubMed ID: 31939597
[TBL] [Abstract][Full Text] [Related]
12. Interaction of OIP5-AS1 with MEF2C mRNA promotes myogenic gene expression.
Yang JH; Chang MW; Pandey PR; Tsitsipatis D; Yang X; Martindale JL; Munk R; De S; Abdelmohsen K; Gorospe M
Nucleic Acids Res; 2020 Dec; 48(22):12943-12956. PubMed ID: 33270893
[TBL] [Abstract][Full Text] [Related]
13. A chromatin-associated splicing isoform of
Wanowska E; Kubiak M; Makałowska I; Szcześniak MW
RNA Biol; 2021 Nov; 18(11):1834-1845. PubMed ID: 33404283
[TBL] [Abstract][Full Text] [Related]
14. LncRNA OIP5-AS1 is overexpressed in undifferentiated oral tumors and integrated analysis identifies as a downstream effector of stemness-associated transcription factors.
Arunkumar G; Anand S; Raksha P; Dhamodharan S; Prasanna Srinivasa Rao H; Subbiah S; Murugan AK; Munirajan AK
Sci Rep; 2018 May; 8(1):7018. PubMed ID: 29728583
[TBL] [Abstract][Full Text] [Related]
15. LncRNA OIP5-AS1 inhibits osteoblast differentiation of valve interstitial cells via miR-137/TWIST11 axis.
Zheng D; Wang B; Zhu X; Hu J; Sun J; Xuan J; Ge Z
Biochem Biophys Res Commun; 2019 Apr; 511(4):826-832. PubMed ID: 30846207
[TBL] [Abstract][Full Text] [Related]
16. OIP5-AS1: A Fascinating Long Noncoding RNA in Carcinoma.
Zhong J; Chen J; Wang B; Zhou Z; Shen Y; Gong Y; Tan F; Yuan C
Curr Pharm Des; 2021; 27(46):4699-4706. PubMed ID: 34579624
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA OIP5-AS1 promotes the stemness of lung cancer cells through enhancing Oct4 mRNA stability.
Mao C; Li X
Environ Toxicol; 2022 May; 37(5):1104-1112. PubMed ID: 35044041
[TBL] [Abstract][Full Text] [Related]
18. LncRNA OIP5-AS1 aggravates the stemness of hepatoblastoma through recruiting PTBP1 to increase the stability of β-catenin.
Jiang W; Ou ZL; Zhu Q; Yao YB; Zai HY
Pathol Res Pract; 2022 Apr; 232():153829. PubMed ID: 35255389
[TBL] [Abstract][Full Text] [Related]
19. The role of lncRNA OIP5-AS1 in cancer development and progression.
Zheng C; Chu M; Chen Q; Chen C; Wang ZW; Chen X
Apoptosis; 2022 Jun; 27(5-6):311-321. PubMed ID: 35316453
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA OIP5-AS1 accelerates the ox-LDL mediated vascular endothelial cells apoptosis through targeting GSK-3β via recruiting EZH2.
Wang M; Liu Y; Li C; Zhang Y; Zhou X; Lu C
Am J Transl Res; 2019; 11(3):1827-1834. PubMed ID: 30972206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
